Stockreport

Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025

Longeveron Inc. - common stock  (LGVN) 
PDF MIAMI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rar [Read more]